References
- Dundar M, Fahrioglu U, Yildiz SH, Bakir-Gungor B, Temel SG, Akin H, et al. Clinical and molecular evaluation of MEFV gene variants in the Turkish population: A study by the National Genetics Consortium. Funct Integr Genom. 2022;22:291-315. DOI: 10.1007/s10142-021-00819-3
- Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017;36:1707-1713 DOI: 10.1007/s10067-017-3715-5
- Soriano A, Manna R. Familial Mediterranean fever: New phenotypes. Autoimmun Rev. 2012;12:31-37 DOI: 10.1016/j.autrev.2012.07.019
- Chaaban A, Salman Z, Karam L, Kobeissy PH, Ibrahim JN. Updates on the role of epigenetics in familial mediterranean fever (FMF). Orphanet Journal of Rare Diseases. 2024;19(1):90 DOI: 10.1186/s13023-024-03098-w
- De Torre-Minguela C, Mesa del Castillo P, Pelegrín P. The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 2017;8:43 DOI: 10.3389/fimmu.2017.00043
- Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R, et al. An update on familial Mediterranean fever. Int J Molec Sciences. 2023;24(11):9584 DOI: 10.3390/ijms24119584
- Veyssiere M, Aghamiri SS, Cervantes AH, Henry T, Soumelis V. A mathematical model of Familial Medi-terranean Fever predicts mechanisms controlling inflammation. Clin Immunol. 2023;257:109839 DOI: 10.1016/j.clim.2023.109839
- Yigit S, Tural S, Tekcan A, Tasliyurt T, Inanir A, Uzunkaya S, et al. The role of IL-4 gene 70 bp VNTR and ACE gene I/D variants in Familial Mediterranean fever. Cytokine. 2014;67:1-6 DOI: 10.1016/j.cyto.2014.01.007
- Wagner AH, Klersy A, Sultan CS, Hecker M. Potential role of soluble CD40 receptor in chronic inflammatory diseases. Biochem Pharmacol. 2023;217:115858 DOI: 10.1016/j.bcp.2023.115858
- Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E. CD40/CD40L signaling and its implication in health and disease. Biofactors. 2009;35:474-483 DOI: 10.1002/biof.62
- Bonizzi G, Karin M. The two NF-kappa B activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280-288 DOI: 10.1016/j.it.2004.03.008
- Deng ZH, Sun MH, Li YS, Luo W, Zhang FJ, Tian J, et al. Single nucleotide polymorphisms in the CD40 gene associate with the disease susceptibility and severity in knee osteoarthritis in the Chinese Han population: A case-control study. BMC Musculoskelet Disord. 2017;18:115 DOI: 10.1186/s12891-017-1466-8
- Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879-1885. DOI: 10.1002/art.1780401023
- Nursal AF, Kaya S, Sezer O, Karakus N, Yigit S. MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort. J Clin Lab Anal. 2018;32:e22259 DOI: 10.1002/jcla.22259
- Tufan A, Babaoglu MO, Akdogan A, Yasar U, Calguneri M, Kalyoncu U et al. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J rheumatol. 2007;34(7):1540-1544.
- Keskin O, Yilmaz E, Kutlay S, Bakkaloglu A, Topaloglu R, Arici M et al. Is the CD14 C159T polymorphism effective in the development of secondary amyloidosis in Familial Mediterranean fever?. Rheumatol Int. 2007;27:691-694. DOI: 10.1007/s00296-006-0286-1
- Celebi Kobak A, Kobak S, Kabasakal Y, Akarca US. Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever. Clin rheumatol. 2007;26:908-910. DOI: 10.1007/s10067-006-0430-z
- Balci-Peynircioglu B, Taskiran ZE, Türel B, Arici M, Bakkaloglu A, Ozen S et al. The analysis of interleukin-1 receptor antagonist and interleukin-1beta gene polymorphisms in Turkish FMF patients: do they predispose to secondary amyloidosis. Clin Exp Rheumatol. 2008;26(4 Suppl 50):S99-S102.
- Bezalel Y, Gershoni-Baruch R, Dagan E, Lidar M, Livneh A. The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever. Clin Experimental Rheumatol. 2009;27(2):S103.
- Erken E, Gunesacar R, Ozer HT. Investigation of C5a receptor gene 450 C/T polymorphism in Turkish patients with familial Mediterranean fever. Molecular biology reports. 2010;37:273-276. DOI: 10.1007/s11033-009-9677-1
- Ozen F, Silan C, Uludag A, Candan F, Silan F, Ozdemir S et al. Association between ABCB1 (MDR1) gene 3435 C> T polymorphism and colchicine unresponsiveness of FMF patients. Renal failure.2011;33(9):899-903. DOI: 10.3109/0886022X.2011.605980
- Rüstemoglu A, Gumus-Akay G, Yigit S, Tasliyurt T. Analysis of common MDR1 (ABCB1) gene C1236T and C3435T polymorphisms in Turkish patients with familial Mediterranean fever. Genet Mol Res. 2011;10(4):3411-20. DOI: 10.4238/2011.December.14.7
- Bonyadi M, Bahrami S, Jahanafrooz Z, Dastgiri S. Tumor necrosis factor-α gene polymorphisms in FMF and their association with amyloidosis. Clinical and Applied Thrombosis/Hemostasis. 2012;18(6):633-637. DOI: 10.1177/1076029611432743
- Dundar M, Kiraz A, Balta B, Emirogullari EF, Zararsiz G, Yurci A et al. The role of TNF-α and PAI-1 gene polymorphisms in familial Mediterranean fever. Modern Rheumatol. 2013;23:140-145. DOI: 10.3109/s10165-012-0687-9
- Gunesacar R, Erken E, Dinkci S. Analysis of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Promoter− 318C/T and+ 49A/G Gene Polymorphisms in Turkish Patients with Familial Mediterranean Fever. Cell biochem biophys. 2013;65:181-186. DOI: 10.1007/s12013-012-9416-4
- Dogruer D, Tug E, Bes C, Soy M. Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever. Genet Mol Res. 2013;12(3):3521-8. DOI: 10.4238/2013.January.24.2
- Migita K, Agematsu K, Masumoto J, Ida H, Honda S, Jiuchi Y et al. The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population. PLoS One. 2013;8(2):e55227. DOI: 10.1371/journal.pone.0055227
- Öktem F, Anıl H, Sütcü R, Kuybulu AE. Genetic polymorphisms of paraoxonase1 192 and glutathione peroxidase1 197 enzymes in familial Mediterranean fever. Genet Mol Res. 2014;13(2):3292-300. DOI: 10.4238/2014.April.29.7
- El Hawary R, Elanwary S, Meshaal S. Mediterranean fever gene mutations: correlation with cytotoxic T-lymphocyte-associated antigen 4 gene polymorphism. Microbiol immunol. 2015;59(3):160-165. DOI: 10.1111/1348-0421.12229
- Ibrahim JN, Chouery E, Lecron JC, Mégarbané A, & Medlej-Hashim M. Study of the association of IL-1β and IL-1RA gene polymorphisms with occurrence and severity of Familial Mediterranean fever. Eur J Med Genetics. 2015;58(12):668-673. DOI: 10.1016/j.ejmg.2015.11.007
- Wilson M, Abou-Elalla AA, Zakaria MT, Marzouk H, Fayed HL, Hanna MOF. Serum amyloid A Type 1 gene polymorphism in Egyptian children with familial Mediterranean fever. Pathobiology. 2016;83(6):295-300. DOI: 10.1159/000444933
- Ozer S, Yilmaz R, Sonmezgoz E, Unuvar S, Ates O. Is the IL-6 -174G/C Gene Polymorphism Related to the Disease Severity Score in Turkish Children with Familial Mediterranean Fever?. Biochem Genet. 2016;54:886-893. DOI: 10.1007/s10528-016-9764-7
- Nursal AF, Tekcan A, Kaya SU, Sezer O, Yigit S. Interleukin-1Ra rs2234663 and interleukin-4 rs79071878 polymorphisms in familial Mediterranean fever. Gene. 2016;582(2):173-177. DOI: 10.1016/j.gene.2016.02.008
- Küçükşahin O, Şeker Z, Şahin A, Kinikli G, Tuncali T, Turgay M et al. Lack of the Association of the PTPN22 C1858T Gene Polymorphism With Susceptibility to Familial Mediterranean Fever. Archives of rheumatology. 2016;31(2):107. DOI: 10.5606/ArchRheumatol.2016.5788
- Ozel EG, Duran GG, Celik MM, Duran N, Gunesacar R. Fas and Fas ligand gene polymorphisms in Turkish patients with Familial Mediterranean Fever. Gene. 2017;623:29-32. DOI: 10.1016/j.gene.2017.04.037
- Erken E, Kudaş Ö, Dinkçi S, Kuyucu Y, Taşlıyurt T, Erken E. Mannose binding lectin (mbl) gene polymorphisms and their relations with clinical features in patients with familial mediterranean fever (fmf). Journal of Istanbul Faculty of Medicine. 2017;80(4):125-130. DOI: 10.18017/iuitfd.348847
- Marzouk H, Farag Y, El-Hanafi HM, Ibrahim E. Serum IL 4 and its gene polymorphism (rs79071878) in Egyptian children with familial Mediterranean fever. Clin Rheumatol. 2018;37:3397-3403. DOI: 10.1007/s10067-018-4214-z
- Yigit S, Nursal AF, Keskin A, Kaya S, Kuruca N, Sezer O. Association of MIF-173G/C, IL-4 VNTR, and IL-1RA VNTR variants with FMF-related amyloidosis in a Turkish cohort. J Investigative Med. 2024;72(1):17-25. DOI: 10.1177/10815589231207789
- Krishnappa P, Kong HM, Mohamad IB, Voon K, Somanath SD. CD40 polymorphism in cervical carcinoma in a subset of Malaysian population. J Obstet Gynaecol Res. 2017;43:923-928 DOI: 10.1111/jog.13277
- Zhang B, Wu T, Song C, Chen M, Li H, Guo R. Association of CD40--1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population. Int Immunopharmacol. 2013;16:461-465 DOI: 10.1016/j.intimp.2013.04.028
- Liu ZL, Hu J, Xiao XF, Peng Y, Zhao SP, Xiao XZ, et al. The CD40 rs1883832 polymorphism affects sepsis susceptibility and sCD40L levels. BioMed Res. Int. 2018;2018:7497314 DOI: 10.1155/2018/7497314
- Wang D, Chen J, Zhang H, Yang L, Mou Y. Role of different CD40 polymorphisms in Graves’ disease and Hashimoto’s thyroiditis. Immunol Invest. 2017;46:544-551 DOI: 10.1080/08820139.2017.1319382
- Hamta A, Safaei PG. Evaluating the relationship between polymorphisms in the CD40 gene with the prevalence of breast cancer: A case-control study. Med J Tabriz Uni Med Sciences. 2023;45(4) DOI: 10.34172/mj.2023.34
- Tian S, Wang Y, Wan J, Yang M, Fu Z. Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review. Medicine. 2024;103(14):e37718 DOI: 10.1097/MD.0000000000037718
- Vermersch P, Wagner D, Mars L T, Noelle R, Giovannoni G. Inhibiting CD40 Ligand in Multiple Sclerosis: A Review of Emerging Therapeutic Potential. Current Treatment Options in Neurology. 2025;27(1):7 DOI: 10.1007/s11940-024-00818-2
- Ahmed HA, Abdelkreem E, Hamed EO, Abo Elmahassen NM, Younis MAA. Frequency of CD40-1C> T polymorphism (rs1883832) and association with response to treatment in children with primary immune thrombocytopenia. Pediatric Blood & Cancer. 2024;71(12):e31356 DOI: 10.1002/pbc.31356
- Gümüş A, Sönmez D, Demirkol Ş, Tolgahan Hakan M, Verim A, Süoğlu Y, et al. Impact of CD40 (rs1883832) and CD40L (rs1126535) gene variants on laryngeal cancer susceptibility and their association with serum biomarker levels of sCD40 and sCD40L. PloS one. 2014;19(12):e0312576 DOI: 10.1371/journal.pone.0312576
- Joshi P, Mohr F, Rumig C, Kliemank E, Krenning G, Kopf S, et al. Impact of the-1T> C single-nucleotide polymorphism of the CD40 gene on the development of endothelial dysfunction in a pro-diabetic microenvironment. Atherosclerosis. 2024;394:117386 DOI: 10.1016/j.atherosclerosis.2023.117386
- Inal EE, Rüstemoğlu A, Inanır A, Ekinci D, Gül Ü, Yiğit S, et al. Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Behçet’s disease. Rheumatol Int. 2015;35:837-843 DOI: 10.1007/s00296-014-3171-3
- Abd El Dayem OY, Aboukhalil REA, Abd Elhady M, Masoud M, Abou-Elalla AA. Impact of CD40 gene variants [(rs1883832) and (rs4810485)] on the risk of immune thrombocytopenic purpura in Egyptian paediatric patients: a case-control study. Egyptian J Haematol. 2024;49(1):10-21 DOI: 10.4103/ejh.ejh_77_23
- Shi Z, Zhang Q, Chen H, Miao X, Liu J, Lian Z, et al. Association of CD40 gene polymorphisms with susceptibility to neuromyelitis optica spectrum disorders. Molec Neurobiol. 2017;54:5236-5242 DOI: 10.1007/s12035-016-0070-5
- Dolen Y, Yilmaz G, Esendagli G, Guler N, Guc D. CD40 -1C >T single nucleotide polymorphism and CD40 expression on breast tumors. Cytokine 2010;50:243-244 DOI: 10.1016/j.cyto.2010.03.010
- Kuo HC, Chao MC, Hsu YW, Lin YC, Huang YH, Yu HR, et al. CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population. Sci World J. 2012;2012: 520865 DOI: 10.1100/2012/520865
- Budlewski T, Sarnik J, Galita G, Dragan G, Brzezińska O, Popławska M, et al. SNP in PTPN22, PADI4, and STAT4 but Not TRAF1 and CD40 Increase the Risk of Rheumatoid Arthritis in Polish Population. Int J Molec Sci. 2023;24(8):7586 DOI: 10.3390/ijms24087586
- Zhu M, Li X, Feng Y, Jia T, Li S, Gong L, et al. Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study. BMC cancer. 2023; 23(1):845 DOI: 10.1186/s12885-023-11367-3
- Shuang C, Dalin L, Weiguang Y, Zhenkun F, Fengyan X, Da P, et al. Association of CD40 gene polymorphisms with sporadic breast cancer in Chinese Han women of Northeast China. PloS one. 2011;6(8):e23762. DOI: 10.1371/journal.pone.0023762